Ewing sarcoma is a pediatric bone tumor characterized in 85% of cases by the fusion between EWS and FLI1 genes that results in the expression of the EWS-FLI1 aberrant transcription factor. Histologically, the Ewing tumor expresses high levels of the CD99 membrane glycoprotein. It has been recently described that CD99 expression contributes to the Ewing tumor oncogenesis by modulating growth and differentiation of tumor cells. Different studies have also shown that overexpression of EWS-FLI1 induces CD99 expression in non-Ewing cells. At the opposite, the knockdown of EWS-FLI1 expression by siRNA approaches has no significant effect on CD99 mRNA level in Ewing cells. Here, by in vivo and in vitro studies, we show that while EWS-FLI1 inhibition has only slight effects on the amount of CD99 transcript, it induces a dramatic decrease of the CD99 protein expression level, hence suggesting post-transcriptional regulations, possibly mediated by microRNAs. To further investigate this issue, we identified a set of 91 miRNAs that demonstrate EWS-FLI1 modulation, three of them being predicted to bind CD99 3 0 untranslated region (3 0 UTR). Among these, we show that miR-30a-5p has the ability to interact with the 3 0 UTR region of CD99 and to regulate its expression. Moreover, the re-expression of miRNA-30a-5p in Ewing cell line induces decreased cell proliferation and invasion. In this study, we therefore show that miR-30a-5p constitutes a major functional link between EWS-FLI1 and CD99, two critical biomarkers and therapeutic targets in Ewing sarcoma.
INTRODUCTION
Ewing sarcoma is the second most frequent bone tumor affecting children and adolescents with a peak incidence at 15 years of age. This tumor expresses two peculiar markers that are both of diagnostic significance and that constitute attractive therapeutic targets.
First, it is most frequently characterized by a recurrent chromosome t(11;22)(q24;q12) translocation that results in a chimeric transcript encoding the N-terminal trans-activating of EWS and the DNA-binding domain of ETS transcription factor. 1 EWS-FLI1 encodes a transcription factor which is thought to contribute to oncogenesis through the abnormal regulation of specific target genes by affecting both gene transcription 2, 3 and RNA splicing. [4] [5] [6] The knockdown of EWS-FLI1 in vivo or in vitro by siRNA induces growth arrest, apoptosis and differentiation of Ewing cell lines (reviewed in Toomey et al. ). EWS-FLI1 has the ability to induce tumorigenicity of immortalized NIH3T3 cells. 7, 8 Accordingly, the gene expression profiling of Ewing cell lines invalidated for EWS-FLI1 has shown that this oncogene regulates the expression of a variety of genes implicated in cell-cycle regulation, apoptosis, migration, cell proliferation and differentiation. 3 Finally, EWS-FLI1 is sufficient to transform mesenchymal progenitor cells and to induce the formation of tumor displaying characteristics of Ewing tumors in mouse model. 9, 10 These different characteristics identify EWS-FLI1 as a major oncogene in Ewing sarcoma.
Second, Ewing sarcoma displays high expression of the CD99 membrane glycoprotein. Although not fully specific for Ewing sarcoma, an intense membrane staining for CD99 constitutes a strong criteria to distinguish Ewing sarcoma from other types of small round cell tumors of childhood. CD99 is a ubiquitous 32 kDa trans-membrane glycoprotein encoded by the pseudoautosomal MIC2 gene. This protein is implicated in T-cell receptor costimulation and in several cellular processes such as cell adhesion and migration, 11, 12 apoptosis 13, 14 and transport of surface molecule. 15, 16 In Ewing cell lines, engagement of CD99 by specific antibodies induces apoptosis, defect of cell migration and of cell-cell adhesion. [17] [18] [19] Moreover, by siRNA approach, it was recently shown that the silencing of CD99 significantly inhibits the in vitro and in vivo proliferation and migration properties of Ewing cell lines. 20, 21 These data suggest not only that CD99 constitutes an important marker for Ewing sarcoma cells, but even more importantly that it may be involved in the Ewing tumor oncogenesis and hence constitute an interesting therapeutic target. Numerous data suggest a functional link between EWS-FLI1 and CD99. The overexpression of EWS-FLI1 induces CD99 expression in human mesenchymal progenitor cells, 22 that EWS-FLI1 interacts with the CD99 promoter but does not modify its mRNA level. These data suggest a complex mechanism of regulation of CD99 expression by EWS-FLI1.
MicroRNAs (miRNAs) are non-coding small RNAs of 19-25 nucleotides that have a crucial function in post-transcriptional regulation of gene expression by inhibition of translation or by degradation of mRNA. The action of miRNA is mediated by the binding of the 'seed sequence' encompassing the first 2-8 bases of the mature miRNA sequence on complementary sequence in the 3 0 untranslated region (3 0 UTR) of target genes. MiRNAs have been implicated in the pathogenicity of cancers through oncogene or tumor suppression mechanisms of action (for review, Esquela-Kerscher and Slack 26 ). The implication of miRNAs in the oncogenesis of Ewing sarcoma has been recently investigated. [27] [28] [29] It was shown that EWS-FLI1 modulates the expression of specific miRNAs and more particularly of the miRNA-145 that has important roles in Ewing cell differentiation and tumorigenicity. Moreover, McKinsey et al. 28 have identified a group of miRNAs that are repressed by EWS-FLI1 and that act on the modulation of IGF-1/IGF-1R signaling, a critical pathway in the oncogenesis of Ewing tumor. Finally, the let-7a miRNA was described as a direct target of EWS-FLI1 that participates in vivo in Ewing cell tumorigenicity via the induction of HMGA2 expression. 30 Here, we hypothesized that miRNAs may be involved in the regulation of CD99 by EWS-FLI1. By in vitro and in vivo studies, we show that the knockdown of EWS-FLI1 expression in Ewing cell lines induces a dramatic decrease of CD99 protein level with only a slight decrease of the mRNA level suggesting a post-transcriptional regulation. To address the implication of miRNAs on the regulation of CD99 expression, we searched for miRNAs modulated by EWS-FLI1 by a microarray miRNA profiling approach. The set of miRNAs downregulated by EWS-FLI1 was compared with the miRNAs predicted to target the 3 0 UTR of CD99. Our data show that EWS-FLI1 induces the high expression of CD99 in Ewing sarcoma through inhibition of miRNA-30a-5p expression. In agreement with this observation, the re-expression of miRNA30a-5p in Ewing cell line decreases the cell proliferation and invasion via the silencing of CD99 expression.
RESULTS AND DISCUSSION
The shA673-1C clone in which EWS-FLI1 is controlled by a tetracycline-inducible small hairpin RNA directed against the junction between the EWS and FLI1 genes was subcutaneously injected into severe combined immuno deficiency (SCID) mice. Upon appearance of the tumors, doxycycline (DOX) was added in the drinking water of a subset of mice. Whereas tumors grew rapidly in untreated mice, the growth of tumors was almost completely arrested in the DOX-treated group of mice ( Figure 1a) . As a control, we checked that tumors from the parental clone (A673-TER), which express the Tet repressor but does not contain the EWS-FLI1-specific shRNA, were not influenced by DOX treatment therefore ruling out an effect of DOX per se in tumor growth inhibition (Figure 1a ). After 2 weeks of DOX treatment, mice were killed and EWS-FLI1 expression was investigated. EWS-FLI1 mRNA and protein were strongly decreased in the tumors of DOX-treated mice (Figures 1 b and c) . To further characterize the tumors in DOX-treated and untreated mice, we used anti-CD99 antibodies. In untreated tumors, we observed the expected strong membrane staining of CD99 that constitutes a hallmark of Ewing 0 s sarcoma ( Figure 2a) . In striking contrast, almost no membrane staining with the anti-CD99 antibody was observed in tumors of DOX-treated mice (Figure 2a ). This strongly decreased the expression of the CD99 protein that was confirmed by western blot (Figure 2b ). It was also confirmed in vitro by immunofluorescence. As shown in Figure 2c , in normal growth conditions, an intense CD99 membrane staining was observed. It was associated with a significant Golgi staining as shown by co-staining with 32 The Tet repressor-expressing clone (A673-TETR) is used as a control of DOX effects. Twenty millions cells were subcutaneously injected into ten female severe combined immuno deficiency (SCID) mice (C.B-17/lcr-Prkdcscid/lcrlcoCrl; Charles River Company, L'Arbresle, France). The tumor volume (mm 3 ) was calculated using the following formula: (width) 2 Â length/2. When the size of tumor reached a volume of 100 mm 3 (day 0), the normal drinking water of five mice was replaced with water containing 5% of sucrose and 2 mg/ml of DOX. Every 2-3 days, the tumor growth was measured and the DOX containing water was changed. The tumors were harvested at day 16 after DOX treatment. All experimental procedures were performed in strict accordance with the recommendations of the European Community (86/609/EEC) and the French National Committee (87/848) for care and use of laboratory animals. All animal experiments were carried out under the supervision of an investigator authorized by French Competent Veterinary Authority. (b) RT-QPCR and (c) western blot analyses of EWS-FLI1 expression in shA673-1C xenografts. Total RNAs were extracted using the TRIzol reagent (Invitrogen, Life Technologies, Saint Aubain, France). One microgram was reverse transcribed with oligonucleotide-random hexamers using the High Capacity cDNA Reverse Transcription kit (Applied Biosystems, Life Technologies, Saint Aubain, France). EWS-FLI1 was quantified by SYBR green with specific primers as previously described. 32 The relative mRNA expression was determined by the comparative cycle threshold method using the housekeeping gene GAPDH. Proteins were extracted in 8 M urea as previously described. 49 Sixty micrograms of proteins were resolved by 10% SDS-PAGE and transferred onto nitrocellulose membrane (Bio-Rad, Marnes la Coquette, France). Blots were incubated with anti-FLI (7.3) antibody (1:10 000 dilution; Melot et al. 50 ) and a monoclonal mouse anti-b actin antibody (1:10 000 dilution; Sigma-Aldrich, Saint Quentin Fallavier, France) as an internal control of loading. For FLI1, the protein A coupled to horseradish peroxidase (1:10 000 dilution; Amersham, GE Healthcare Europe, Freibourg, Germany) was used. b-Actin signal was detected using horseradish peroxidase-conjugated mouse antibody (1:3000 dilution; Amersham). Figure 2c ). In contrast, in the presence of DOX in the culture medium, an almost complete disappearance of CD99 membrane staining was observed with only a residual Golgi staining (Figure 2c ). The dramatic decrease of CD99 expression upon EWS-FLI1 knockdown that was observed both in vivo and in vitro strongly contrasted with the modest decrease of CD99 mRNA expression that could be detected by Q-PCR experiments (Figure 2d ). This was consistent with the absence of significant CD99 regulation observed in various microarray experiments performed following EWS-FLI1 inhibition. 31, 32 To further investigate the relationship between EWS-FLI1 and CD99, we hypothesized that EWS-FLI1 regulates specific miRNAs that may in turn regulate CD99. To address this question, we postulated that such miRNAs should both be regulated by EWS-FLI1 and have the ability to bind the CD99 mRNA. We therefore compared the set of miRNAs predicted to target CD99 3 0 UTR using a variety of prediction softwares (Target Scan program, miRanda algorithm and miRDB program) and the set of EWS-FLI1-regulated miRNAs (Supplementary Figure S1) . The analysis of miRNAs in Ewing cell line invalidated for EWS-FLI1 showed the modulation of expression of 91 miRNAs with a fold change higher than two including the miR-145 that was recently described as a specific target of EWS-FLI1. 27, 29 In these manuscripts, the authors have shown a reciprocal regulation loop between EWS-FLI1 and miRNA-145 to induce the expression of specific genes acting in Ewing cells growth and differentiation and consequently in the tumorigenicity of this sarcoma. Among the 91 miRNAs modulated by EWS-FLI1, miR-30a-5p, miR-190 and miR-205 present putative binding sites on the CD99 3 0 UTR. Whereas two potential binding regions were identified for miR-30a-5p, only one seed region was identified for miR-190 and miR-205 (Figure 3a) . To further investigate these miRNAs, reporter assays were conducted investigating the effect of mimics of these miRNAs on a reporter system where the CD99 3 0 UTR was cloned downstream of the Renilla luciferase gene. As compared with the control miRNA, a significant decrease of the Renilla luciferase activity was observed with miR-30a-5p and miR-190 mimics (Figure 3b ). In contrast, no effect was observed with miR-205. No additive effect of miR-30a-5p and miR-190 was observed (data not shown). For subsequent experiments, we focused our attention on the miR-30a-5p that demonstrated the strongest effect in this assay (Figure 3b ). To further document the relationship between miR-30a-5p and CD99 expression, we performed mutagenesis of the two putative miR30a-5p seed regions of CD99 (Figure 3a) . As shown in Figure 3c , whereas mutagenesis of both seed regions resulted in a complete loss of the effect of the miR-30a-5p mimic on Renilla luciferase expression, mutagenesis of either region led to an intermediary effect. This therefore showed that the two regions mediate miR30a-5p effect on CD99 expression. This was also confirmed by the analysis of the expression of CD99 by FACS upon transfection of 0 UTR containing Renilla luciferase reporter by miR-30a-5p and miR-190. The CD99 3 0 UTR (503 bp) was PCR amplified and cloned into the Not1/Xho1 sites of the 3 0 region of Renilla luciferase gene reporter of the psicheck2 plasmid (Promega, Charbonnieres, France). The psicheck2/CD99 3 0 UTR WT reporter construct together with microRNA mimics were co-transfected in HEK293T cells. The activity of Renilla luciferase (hRluc) was normalized to the internal Firefly luciferase control (hLuc þ ) encoded by the same vector. MicroRNA mimics of miR-30a-5p, miR-190, miR-205 and a negative control mimic (miR-ctl) were obtained from Thermo Scientific Dharmacon (Brebières, France) (miRIDIAN microRNA Mimics). Firefly luciferase and Renilla luciferase activities were measured using the DualLuciferase Reporter assay system (Promega) in quadruplicate according to manufacturer's recommendations. Each error bar represents the average of two independent experiments. (c) MicroRNA-30a-5p-mediated regulation of CD99 expression through two CD99 3 0 UTR binding sites. The two putative binding sites of miR-30a-5p on the 3' UTR of CD99 that were mutated in the two 'seed regions' are underlined in (a). The activity of Renilla luciferase (hRluc) was normalized to the internal Firefly luciferase control (hLuc þ ). The mutagenesis of the both 'seed regions' (six nucleotides) of miR-30a-5p on the CD99 3 0 UTR was performed using the QuickChange II XL site-directed mutagenesis kit (Stratagene, Agilent Technologies, Massy, France) according to manufacturer's instructions. Three plasmid constructions were performed: psicheck2/3 0 UTR CD99 mut1 (the first seed region GUUUAC was mutated into AGGCCT), psicheck2/3 0 UTR CD99 mut2 (the second seed region UGUUUA was mutated into CACGCG) and psicheck2/3 0 UTR CD99 mut1 þ 2 (mutation of the both seed regions). (d) Decreased CD99 membrane expression by miR-30a-5p in Ewing cell lines (A673 and EW24). The miR-30a-5p mimic (20 nM) was transfected using Lipofectamine RNAiMAX (Invitrogen) according to manufacturer's protocol. After 2 days, cells were suspended in 2% SVF-HBSS and incubated with anti-CD99 O13 antibody (1:50 dilution; Thermo Scientific, Brebières, France) on ice for 1 h. After washing of the cell pellet with 2% SVF-HBSS, the secondary anti-mouse antibody coupled to FITC (1:100 dilution; Dako) was added for 30 min on ice. Stained cell analyses were performed using a FACScalibur apparatus (BD Biosciences, San Diego, CA, USA).
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Ewing cell lines with a miR-30a-5p mimic. In the two tested Ewing cell lines, miR-30a-5p enforced expression led to a strong decrease of CD99 expression (Figure 3d ). Altogether these data show that miR-30a-5p decreases CD99 expression through interaction with its 3 0 UTR. Given that miR-30a-5p decreases essentially the CD99 protein level, we can speculate that miR-30a-5p acts on CD99 expression mostly by repression of translation as reported for other miRNAs. 33 To further investigate the mechanisms of miR-30a-5p regulation by EWS-FLI1, we cloned the putative miR-30a-5p promoter upstream of the Firefly luciferase gene. This construct was transfected in HEK293T cells together with EWS-FLI1 or control expression vectors. In the presence of EWS-FLI1, a dramatic decrease of the Renilla luciferase expression was observed strongly suggesting that EWS-FLI1 negatively regulates the miR30a-5p promoter (Supplementary Figure S2) . However, as compared with the cyclin D1 promoter region, ChIP experiments could not detect a direct in vivo binding of EWS-FLI1 to the miR30a-5p promoter region (Supplementary Figure S2) . This therefore 
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-actin A673-miR30a-5p Figure 4 . The stable expression of miR-30a-5p in A673 Ewing cell line induces a decreased cell proliferation and invasion associated with decreased CD99 expression. (a) Expression of miR-30a-5p in A673 cells. The pre-miR-30a-5p was amplified with 50 ng of genomic DNA of A673 cell line and the couple of primer F (GCATCTCGAGGCTGTTTGAATGAGGCTTCA) and R (GCATCTCGAGCCATTTTAATTCAGCTTTGT). The DNA amplified was cloned into XhoI sites of pNL-SIN-CMV-eGFP lentiviral vector (gift of BR Cullen, Durham, NC, USA). The production of lentiviral particles was performed as described by Lee et al. 51 The A673 cell line was infected with empty vector or miR-30a-5p vector with an multiplicity of infection (MOI) of 5 and the cells infected were selected by FACS using eGFP as reporter gene. (b) Western blot was hybridized with anti-CD99 12E7 (1:1000 dilution) and the quantification of CD99 was performed relative to b-actin expression. Proliferation (c) and invasion (d) assays; the cellular growth was performed by viable cell counting with the method of blue trypan exclusion at day 3 after plating and the error bar corresponds to three biological replicates. The invasive property of Ewing cell line by re-expressing miR-30a-5p (A673-miR-30a-5p) was assessed with matrigel invasion chambers (BD Biosciences). In all, 5 Â 10 5 cells were seeded in the chamber with DMEM and 0.5% of FBS and the lower chamber with medium containing 10% of FBS. After 2 days, the invasive cells were stained with violet crystal and counted. Data correspond to the number of migrated cells calculated with eight random areas on the matrigel membrane and performed on two independent experiments.
suggests that the mechanism of regulation of the miRNA-30a-5p promoter by EWS-FLI1 may not be direct.
Interestingly, it was recently shown that EWS-FLI1 and CD99 knockdown signatures in Ewing cells present a significant overlap and that EWS-FLI1 binds in vivo to the CD99 promoter suggesting that CD99 is a direct target of EWS-FLI1. 21 However, these convincing data contrast with the only slight decrease of the CD99 transcript that is observed by us and others following EWS-FLI1 knockdown (Figure 2d) . We believe that our data may reconcile these different results showing that EWS-FLI1 has dramatic effects on CD99 expression not only through transcription regulation of CD99 but also through translation regulation by miR-30a-5p that target the 3 0 UTR of CD99. This double mechanism of regulation by EWS-FLI1 on the transcription and post-transcription of specific targets is reminiscent of what has been recently described for the IGF-1 pathway. EWS-FLI1 regulates directly 34 and indirectly, via miR-27a, the expression of the IGF-1 protein. 28 MiR-30a-5p belongs to the miR-30 family which is implicated in different cellular functions such as apoptosis, 35 senescence, 36 adipocyte and embryonic stem cells differentiation. 37, 38 In human cancers, it has been observed that the expression of the miRNA-30 family is downregulated in leukemia, 39, 40 colon, 41, 42 as well as in lung, 43 liver 44 and pancreatic cancers. 45 Moreover, miR-30a, -30d, -30e exhibit low expression in human metastatic cancers 46 and the knockdown of miR-30e increases the tumorigenesis and metastasis of breast cancer cells model overexpressing miR-30e. 47 Recently, it has been demonstrated that the re-expression of miR30a in human non-small cell lung cell lines inhibits the invasion, the migration and the formation of metastasis. 48 Altogether, these data strongly suggest that the miR-30 family members, and more precisely miR-30a, have a tumor suppressor function. To determinate the effects of miR-30a-5p on the tumorigenesis of Ewing cells, we established an Ewing cell line stably expressing a mature miR-30a-5p. The A673 cell line was infected either with the pNL-SIN-CMV-eGFP empty lentiviral vector (A673-empty vector) or with the same vector encoding the pre-miR-30a-5p (A673-miR30a-5p). After selection of eGFP-positive cells by flow cytometry, the expression level of mature miR-30a-5p was quantified by RT-QPCR. The expression level of miR-30a-5p was B10 times higher in A673-miR-30a-5p cells than in control cells (A673-empty vector) and was associated with a dramatic decrease of CD99 (Figures 4a and b) . Moreover, A673-miR-30a-5p cells demonstrated strong decrease of cell proliferation and invasion as compared with control cells (Figures 4c and d) . Similar results for decreased proliferation were obtained for SKNMC and EW24 cells (data not shown). These cells could not be used for invasion assay due to their very low basal invasion. We independently confirmed that CD99 knockdown inhibits cell proliferation in different Ewing cell lines (Supplementary Figure S3) . However, in A673 cells, we failed to rescue miR-30a-5p effects by a CD99 cDNA lacking the 3 0 UTR. This may suggest that, in addition to CD99, miR-30a-5p modulates other targets that also impact cell proliferation. Altogether these data strongly suggest that CD99 is a major target of the miR-30a-5p tumor suppressive function in Ewing sarcoma, though it remains to be investigated whether other targets may also contribute to this effect.
In conclusion, we show that miR-30a-5p provides an essential link between EWS-FLI1 and CD99, two major biomarkers in Ewing sarcoma. Importantly, these two diagnostic markers constitute also very attractive therapeutic targets. Indeed, numerous reports have indicated that EWS-FLI1 inactivation leads to growth arrest and apoptosis. 3 However, EWS-FLI1 is a transcription factor and it is notorious that these proteins, unlike enzymes like kinases, are extremely challenging to inactivate specifically by small molecules or antibodies. Although the normal function of CD99 is unknown, it has been shown that targeting this molecule with specific antibodies could be of strong therapeutic benefice. Indeed, engagement by anti-CD99 monoclonal antibodies induces apoptosis, 18, 19 a reduction of the malignant potential of Ewing cells 18 and a modulation of migration and invasion.
